American Journal of Medical Case Reports. 2016, 4(4), 137-139
DOI: 10.12691/AJMCR-4-4-7
Acute Delirium Caused by Single Small Dose of Zolpidem
Hassan Tahir1, , Muhammad Adeel Saleemi1, Christopher Wolfe1 and Vistasp Daruwalla2
1Department of Internal Medicine, Temple University/Conemaugh Memorial Hospital, 1086 Franklin Street, Johnstown, PA 15905, USA
2Department of Radiology, Wayne State University/Detroit Medical Center, 4201 St Antoine St, Detroit, MI 48201, USA
Pub. Date: April 28, 2016
Cite this paper
Hassan Tahir, Muhammad Adeel Saleemi, Christopher Wolfe and Vistasp Daruwalla. Acute Delirium Caused by Single Small Dose of Zolpidem.
American Journal of Medical Case Reports. 2016; 4(4):137-139. doi: 10.12691/AJMCR-4-4-7
Abstract
Zolpidem, a non benzodiazepine hypnotic, exhibits minimal anxiolytic, muscle relaxant, and anticonvulsant properties due to its minimal effect on BZ2 receptors. Due to low drug abuse and better safety profile, Zolpidem has been increasingly used in practice. More number of patients with rare side effects is being reported due to increasing use of this drug. Zolpidem is considered safe and frequently used in hospitals when patients complain of insomnia during their stay in the hospital. In recent years, there have been reported cases of acute delirium and psychosis after zolpidem use. Majority of these rare neuropsychiatric side effects were seen in patients with the history of psychiatric illness and those taking more than 10mg of zolpidem. We present a case of acute agitation, confusion and hallucinations after administration of a small one time dose (5mg) of zolpidem in a male with no prior history of any psychiatric or substance abuse.
Keywords
zolpidem, delirium, psychosis, hypnotics
Copyright
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit
http://creativecommons.org/licenses/by/4.0/
References
[1] | Sanger DJ. The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents. CNS Drugs. 2004; 21:9-15. |
|
[2] | Markowitz JS, Brewerton TD. Zolpidem-induced psychosis. Ann Clin Psychiatry. 1996;8 (2):89-91. |
|
[3] | Eslami-Shahrbabaki M, Barfeh B, Nasirian M. Persistent Psychosis after Abuse of High Dose of Zolpidem. Addiction & Health. 2014;6 (3-4):159-162. |
|
[4] | Harrison T, Keating G. Zolpidem. CNS Drugs. 2005;21: 65-89. |
|
[5] | Hajak G, Bandelow B. Safety and tolerance of zolpidem in the treatment of disturbed sleep: a post -marketing surveillance of 16944 cases. Int Clin Psychopharmacol. 1998;21: 157-167. |
|
[6] | Mortaz Hejri S, Faizi M, Babaeian M. Zolpidem-induced suicide attempt: a case report. DARU Journal of Pharmaceutical Sciences. 2013;21(1):77. |
|
[7] | Ansseau M, Pitchot W, Hansenne M, et al. Psychotic reactions to zolpidem. Lancet. 1992;339(8796):809. |
|
[8] | Brodeur MR, Stirling AL. Delirium associated with zolpidem. Ann Pharmacother 2001;35: 1562-4. |
|
[9] | Hill KP, Oberstar JV, Dunn ER. Zolpidem-induced delirium with mania in an elderly woman. Psychosomatics 2004;45:88-9. |
|
[10] | Toner L.C, Tsambiras B.M, Catalano G, et al. Central nervous system side effects associated with zolpidem treatment. Clin Neuropharmacol. 2000;23(1):54-58. |
|